TAL Education Group (TAL) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-02-28..
- Stock-based compensation / revenue · 12 months: Value 1.43%; Formula and calculation Share-based compensation / revenue. Period ending 2026-02-28..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-02-28; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-02-28. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.43% | Share-based compensation / revenue. Period ending 2026-02-28. $43.09M ÷ $3.01B × 100 ≈ 1.43% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 3.01B USD | |
| Stock-based compensation | 43.09M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 276.04M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-28 | (m) | $3.01B | $43.09M | $276.04M | (m) | (m) | 1.43% | (m) | (m) |
| 2025-02-28 | (m) | $2.25B | $64.94M | $-3.15M | (m) | (m) | 2.89% | (m) | (m) |
| 2024-02-29 | (m) | $1.49B | $88.90M | $-69.23M | (m) | (m) | 5.96% | (m) | (m) |
| 2023-02-28 | (m) | $1.02B | $108.57M | $-90.73M | (m) | (m) | 10.65% | (m) | (m) |
| 2022-02-28 | (m) | $4.39B | $174.83M | $-614.52M | $7.87M | (m) | 3.98% | -78.07× | Reported |
| 2021-02-28 | (m) | $4.50B | $204.94M | $-438.22M | $16.95M | (m) | 4.56% | -25.86× | Reported |
| 2020-02-29 | (m) | $3.27B | $117.94M | $137.44M | $11.82M | (m) | 3.60% | 11.63× | Reported |
| 2019-02-28 | (m) | $2.56B | $77.28M | $341.58M | $17.63M | (m) | 3.02% | 19.38× | Reported |
| 2018-02-28 | (m) | $1.72B | $47.15M | $208.60M | $16.64M | (m) | 2.75% | 12.54× | Reported |
| 2017-02-28 | (m) | $1.04B | $36.12M | $134.59M | $13.14M | (m) | 3.46% | 10.24× | Reported |
| 2016-02-29 | (m) | $619.95M | $25.85M | $85.05M | $7.50M | (m) | 4.17% | 11.34× | Reported |
| 2015-02-28 | (m) | $433.97M | $18.44M | $67.25M | $5.81M | (m) | 4.25% | 11.57× | Reported |
| 2014-02-28 | (m) | $313.90M | $8.35M | $57.40M | (m) | (m) | 2.66% | (m) | (m) |
| 2013-02-28 | (m) | $225.93M | $8.28M | $31.42M | (m) | (m) | 3.67% | (m) | (m) |
| 2012-02-29 | (m) | $177.52M | $7.90M | $21.02M | (m) | (m) | 4.45% | (m) | (m) |
| 2011-02-28 | (m) | $110.59M | $5.31M | $25.57M | $59.21K | (m) | 4.80% | 431.91× | Reported |
| 2010-02-28 | (m) | $69.29M | (m) | $15.41M | $40.64K | (m) | (m) | 379.15× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.